| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 61, 698-704, Copyright © 1985 by Endocrine Society
ARTICLES |
I Huhtaniemi, H Nikula and S Rannikko
Six patients with advanced prostatic cancer were treated with a potent GnRH agonist analog (buserelin, Hoechst; 600 micrograms, intranasally, three times a day) for 6 months. The first 2-6 days of treatment were associated with a 50% elevation (P less than 0.01) in serum testosterone (T) and a simultaneous elevation of 20% (P less than 0.01) in serum prostate-specific acid phosphatase (PAP). Serum T fell to the castrate range (less than 1 nmol/liter) in all patients in 2-3 weeks, and PAP decreased concomitantly in five of the six patients. Serum LH progressively decreased by about 80% during the treatment, whereas a secondary rise of FSH levels occurred after the first month of treatment. The patients were orchiectomized after 6 months of treatment. No differences were found between the pre- and postsurgical levels of serum T or in comparison with those of six patients orchiectomized as the first therapeutic measure. Testicular endogenous T concentrations, LH and FSH receptors, and in vitro T production were measured in three testis samples and compared with those values in testis tissue obtained from five control patients. The endogenous levels and in vitro production of T were depressed by over 95% in testes from agonist-treated patients. The small residual T production responded to hCG stimulation as in control patients. Interestingly, no change was found in testicular LH receptor content, but FSH receptors decreased by 80%. The elevation in serum PAP at the beginning of the agonist treatment and the small residual testicular T production after 6 months may not be clinically important. However, they indicate the necessity of comparative long term studies between orchiectomy and GnRH agonists in the treatment of patients with prostatic cancer.
This article has been cited by other articles:
![]() |
P. Rantakari, L. Strauss, R. Kiviranta, H. Lagerbohm, J. Paviala, I. Holopainen, S. Vainio, P. Pakarinen, and M. Poutanen Placenta Defects and Embryonic Lethality Resulting from Disruption of Mouse Hydroxysteroid (17-{beta}) Dehydrogenase 2 Gene Mol. Endocrinol., March 1, 2008; 22(3): 665 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saloniemi, T. Lamminen, K. Huhtinen, M. Welsh, P. Saunders, H. Kujari, and M. Poutanen Activation of Androgens by Hydroxysteroid (17{beta}) Dehydrogenase 1 in Vivo as a Cause of Prenatal Masculinization and Ovarian Benign Serous Cystadenomas Mol. Endocrinol., November 1, 2007; 21(11): 2627 - 2636. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Savolainen, T. Pakarainen, I. Huhtaniemi, M. Poutanen, and S. Makela Delay of Postnatal Maturation Sensitizes the Mouse Prostate to Testosterone-Induced Pronounced Hyperplasia: Protective Role of Estrogen Receptor-{beta} Am. J. Pathol., September 1, 2007; 171(3): 1013 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhongyi, P. Rantakari, T. Lamminen, J. Toppari, and M. Poutanen Transgenic Male Mice Expressing Human Hydroxysteroid Dehydrogenase 2 Indicate a Role for the Enzyme Independent of Its Action on Sex Steroids Endocrinology, August 1, 2007; 148(8): 3827 - 3836. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sipila, D. A. Pujianto, R. Shariatmadari, J. Nikkila, M. Lehtoranta, I. T. Huhtaniemi, and M. Poutanen Differential Endocrine Regulation of Genes Enriched in Initial Segment and Distal Caput of the Mouse Epididymis as Revealed by Genome-Wide Expression Profiling Biol Reprod, August 1, 2006; 75(2): 240 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Walden, T. D. Butters, R. A. Dwek, F. M. Platt, and A. C. van der Spoel Long-term non-hormonal male contraception in mice using N-butyldeoxynojirimycin Hum. Reprod., May 1, 2006; 21(5): 1309 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, L. Strauss, A. Kaatrasalo, A. Mayerhofer, I. Huhtaniemi, R. Santti, S. Makela, and M. Poutanen Transgenic Mice Expressing P450 Aromatase as a Model for Male Infertility Associated with Chronic Inflammation in the Testis Endocrinology, March 1, 2006; 147(3): 1271 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Santti, L Mikkonen, A Anand, S Hirvonen-Santti, J Toppari, M Panhuysen, F Vauti, M Perera, G Corte, W Wurst, et al. Disruption of the murine PIASx gene results in reduced testis weight J. Mol. Endocrinol., June 1, 2005; 34(3): 645 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Pakarainen, F.-P. Zhang, S. Makela, M. Poutanen, and I. Huhtaniemi Testosterone Replacement Therapy Induces Spermatogenesis and Partially Restores Fertility in Luteinizing Hormone Receptor Knockout Mice Endocrinology, February 1, 2005; 146(2): 596 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ahtiainen, J. Toppari, M. Poutanen, and I. Huhtaniemi Indirect Sertoli Cell-Mediated Ablation of Germ Cells in Mice Expressing the Inhibin-{alpha} Promoter/Herpes Simplex Virus Thymidine Kinase Transgene Biol Reprod, November 1, 2004; 71(5): 1545 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-p. Zhang, T. Pakarainen, F. Zhu, M. Poutanen, and I. Huhtaniemi Molecular Characterization of Postnatal Development of Testicular Steroidogenesis in Luteinizing Hormone Receptor Knockout Mice Endocrinology, March 1, 2004; 145(3): 1453 - 1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, L. Strauss, S. Makela, T. Streng, I. Huhtaniemi, R. Santti, and M. Poutanen Multiple Structural and Functional Abnormalities in the P450 Aromatase Expressing Transgenic Male Mice Are Ameliorated by a P450 Aromatase Inhibitor Am. J. Pathol., March 1, 2004; 164(3): 1039 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. van der Spoel, M. Jeyakumar, T. D. Butters, H. M. Charlton, H. D. Moore, R. A. Dwek, and F. M. Platt Reversible infertility in male mice after oral administration of alkylated imino sugars: A nonhormonal approach to male contraception PNAS, December 24, 2002; 99(26): 17173 - 17178. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pakarinen, S. Kimura, F. El-Gehani, L. J. Pelliniemi, and I. Huhtaniemi Pituitary Hormones Are Not Required for Sexual Differentiation of Male Mice: Phenotype of the T/ebp/Nkx2.1 Null Mutant Mice Endocrinology, November 1, 2002; 143(11): 4477 - 4482. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sipila, T. G. Cooper, C.-H. Yeung, M. Mustonen, J. Penttinen, J. Drevet, I. Huhtaniemi, and M. Poutanen Epididymal Dysfunction Initiated by the Expression of Simian Virus 40 T-Antigen Leads to Angulated Sperm Flagella and Infertility in Transgenic Mice Mol. Endocrinol., November 1, 2002; 16(11): 2603 - 2617. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Rulli, A. Kuorelahti, O. Karaer, L. J. Pelliniemi, M. Poutanen, and I. Huhtaniemi Reproductive Disturbances, Pituitary Lactotrope Adenomas, and Mammary Gland Tumors in Transgenic Female Mice Producing High Levels of Human Chorionic Gonadotropin Endocrinology, October 1, 2002; 143(10): 4084 - 4095. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. El-Gehani, M. Tena-Sempere, H. Ruskoaho, and I. Huhtaniemi Natriuretic Peptides Stimulate Steroidogenesis in the Fetal Rat Testis Biol Reprod, August 1, 2001; 65(2): 595 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, E. Nokkala, W. Yan, T. Streng, N. Saarinen, A. Warri, I. Huhtaniemi, R. Santti, S. Makela, and M. Poutanen Altered Structure and Function of Reproductive Organs in Transgenic Male Mice Overexpressing Human Aromatase Endocrinology, June 1, 2001; 142(6): 2435 - 2442. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Rahman and I. T. Huhtaniemi Ovarian Tumorigenesis in Mice Transgenic for Murine Inhibin {{alpha}} Subunit Promoter-Driven Simian Virus 40 T-Antigen: Ontogeny, Functional Characteristics, and Endocrine Effects Biol Reprod, April 1, 2001; 64(4): 1122 - 1130. [Abstract] [Full Text] |
||||
![]() |
C.H. Nilsson, M. Kaleva, H. Virtanen, A.M. Haavisto, K. Pettersson, and I.T. Huhtaniemi Disparate response of wild-type and variant forms of LH to GnRH stimulation in individuals heterozygous for the LH{beta} variant allele Hum. Reprod., February 1, 2001; 16(2): 230 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Manna, T. El-Hefnawy, J. Kero, and I. T. Huhtaniemi Biphasic Action of Prolactin in the Regulation of Murine Leydig Tumor Cell Functions Endocrinology, January 1, 2001; 142(1): 308 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Manna, J. Kero, M. Tena-Sempere, P. Pakarinen, D. M. Stocco, and I. T. Huhtaniemi Assessment of Mechanisms of Thyroid Hormone Action in Mouse Leydig Cells: Regulation of the Steroidogenic Acute Regulatory Protein, Steroidogenesis, and Luteinizing Hormone Receptor Function Endocrinology, January 1, 2001; 142(1): 319 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. El-Gehani, M. Tena-Sempere, and I. Huhtaniemi Evidence That Pituitary Adenylate Cyclase-Activating Polypeptide Is a Potent Regulator of Fetal Rat Testicular Steroidogenesis Biol Reprod, November 1, 2000; 63(5): 1482 - 1489. [Abstract] [Full Text] |
||||
![]() |
D. D. Pierroz, A. C. Aebi, I. T. Huhtaniemi, and M. L. Aubert Many LH peaks are needed to physiologically stimulate testosterone secretion: modulation by fasting and NPY Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E603 - E610. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Manna, M. Tena-Sempere, and I. T. Huhtaniemi Molecular Mechanisms of Thyroid Hormone-stimulated Steroidogenesis in Mouse Leydig Tumor Cells. INVOLVEMENT OF THE STEROIDOGENIC ACUTE REGULATORY () PROTEIN J. Biol. Chem., February 26, 1999; 274(9): 5909 - 5918. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Luukkaa, U. Pesonen, I. Huhtaniemi, A. Lehtonen, R. Tilvis, J. Tuomilehto, M. Koulu, and R. Huupponen Inverse Correlation between Serum Testosterone and Leptin in Men J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3243 - 3246. [Abstract] [Full Text] |
||||
![]() |
K. Hakola, D. D. Pierroz, A. Aebi, B. A.M. Vuagnat, M. L. Aubert, and I. Huhtaniemi Dose and Time Relationships of Intravenously Injected Rat Recombinant Luteinizing Hormone and Testicular Testosterone Secretion in the Male Rat Biol Reprod, August 1, 1998; 59(2): 338 - 343. [Abstract] [Full Text] |
||||
![]() |
F. El-Gehani, M. Tena-Sempere, and I. Huhtaniemi Vasoactive Intestinal Peptide Is an Important Endocrine Regulatory Factor of Fetal Rat Testicular Steroidogenesis Endocrinology, April 1, 1998; 139(4): 1474 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tena-Sempere, A. Rannikko, J. Kero, F.-P. Zhang, and I. T. Huhtaniemi Molecular Mechanisms of Reappearance of Luteinizing Hormone Receptor Expression and Function in Rat Testis after Selective Leydig Cell Destruction by Ethylene Dimethane Sulfonate Endocrinology, August 1, 1997; 138(8): 3340 - 3348. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kananen, Rilianawati, T. Paukku, M. Markkula, E.-M. Rainio, and I. Huhtanemi Suppression of Gonadotropins Inhibits Gonadal Tumorigenesis in Mice Transgenic for the Mouse Inhibin {alpha}-Subunit Promoter/Simian Virus 40 T-Antigen Fusion Gene Endocrinology, August 1, 1997; 138(8): 3521 - 3531. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |